High-throughput drug sensitivity and resistance testing of ovarian cancer cell lines provides useful strategy for assessing drug repositioning and therapeutic possibilities of emerging drugs




Hirasawa A, Murumagi A, Arjama M, Yadav B, Mpindi JP, Wennerberg K, Aittokallio T, Aoki D, Kallioniemi O

PublisherAMER ASSOC CANCER RESEARCH

2015

Clinical Cancer Research

CLINICAL CANCER RESEARCH

CLIN CANCER RES

21

16

1

1078-0432

DOIhttps://doi.org/10.1158/1557-3265.OVCASYMP14-POSTER-TECH-1111




Last updated on 2024-26-11 at 10:33